SN. Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£9.73 |
| 52 Week High | UK£12.45 |
| 52 Week Low | UK£9.11 |
| Beta | 0.69 |
| 1 Month Change | -1.42% |
| 3 Month Change | -15.52% |
| 1 Year Change | -9.42% |
| 3 Year Change | -23.94% |
| 5 Year Change | -47.73% |
| Change since IPO | 4,807.98% |
Recent News & Updates
Recent updates
Does Smith & Nephew (LON:SN.) Have A Healthy Balance Sheet?
Dec 15
Investors Still Waiting For A Pull Back In Smith & Nephew plc (LON:SN.)
Oct 31Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital
Sep 25Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are
Aug 08Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around
Jun 16Smith & Nephew plc (LON:SN.) Not Flying Under The Radar
Apr 16Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?
Mar 16Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal
Feb 21Shareholder Returns
| SN. | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -2.5% | -3.5% | -2.6% |
| 1Y | -9.4% | -10.6% | 2.4% |
Return vs Industry: SN. exceeded the UK Medical Equipment industry which returned -10.6% over the past year.
Return vs Market: SN. underperformed the UK Market which returned 2.4% over the past year.
Price Volatility
| SN. volatility | |
|---|---|
| SN. Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 6.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.7% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: SN. has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: SN.'s weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 18,000 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| SN. fundamental statistics | |
|---|---|
| Market cap | UK£8.48b |
| Earnings (TTM) | UK£242.55m |
| Revenue (TTM) | UK£4.49b |
35.0x
P/E Ratio1.9x
P/S RatioIs SN. overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SN. income statement (TTM) | |
|---|---|
| Revenue | US$5.64b |
| Cost of Revenue | US$1.67b |
| Gross Profit | US$3.97b |
| Other Expenses | US$3.66b |
| Earnings | US$305.00m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 70.33% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 66.7% |
How did SN. perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield107%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 00:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/29 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Smith & Nephew plc is covered by 58 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kamla Singh | AlphaValue |
| Christoph Gubler | Bank Vontobel AG |
| Hassan Al-Wakeel | Barclays |